Literature DB >> 12602446

The effects of single-dose fexofenadine, diphenhydramine, and placebo on cognitive performance in flight personnel.

E A Bower1, J L Moore, M Moss, K A Selby, M Austin, S Meeves.   

Abstract

BACKGROUND: Sedation and functional impairments are side effects associated with the use of first-generation antihistamines that preclude their use in aviation. Selected second-generation antihistamines do not have such side effects and have been proposed for use in aircrew.
METHODS: Forty-two healthy naval aviation personnel served as subjects in this double-blind, randomized, placebo-controlled crossover study. Subjective drowsiness, cognitive performance, and vigilance were measured under three conditions: 180 mg fexofenadine (F), 50 mg diphenhydramine (D) as a positive control, or placebo (P).
RESULTS: Subjects receiving F vs. D tended to have a faster mean hit reaction time (adjusted mean difference +/- SE, -10.5 +/- 6.8 ms, p = 0.127). Subjects performed faster and better with F vs. D on measures of omission errors and commission errors (p < 0.05). Variable symbol digit coding delayed recall accuracy was better for F vs. D (p = 0.023), and approached significance for shifting attention and divided attention tasks (p = 0.062 and p = 0.057, respectively). Subjects reported significantly more drowsiness (p < 0.005) with D than F.
CONCLUSIONS: Diphenhydramine administration resulted in significant psychomotor decrements compared with fexofenadine, while the effects of fexofenadine were similar to placebo. These results provide additional support for the safe use of fexofenadine by aviation personnel.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12602446

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  7 in total

Review 1.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Selecting the optimal oral antihistamine for patients with allergic rhinitis.

Authors:  Jeffrey M Lehman; Michael S Blaiss
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis.

Authors:  Leonard Bielory; Kenneth W Lien; Steve Bigelsen
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride.

Authors:  Ignacio J Ansotegui; Jonathan A Bernstein; Giorgio W Canonica; Sandra N Gonzalez-Diaz; Bryan L Martin; Mario Morais-Almeida; Margarita Murrieta-Aguttes; Mario Sanchez Borges
Journal:  Allergy Asthma Clin Immunol       Date:  2022-05-13       Impact factor: 3.373

5.  Histamine H1 receptor blockade predominantly impairs sensory processes in human sensorimotor performance.

Authors:  P van Ruitenbeek; A Vermeeren; F T Y Smulders; A Sambeth; W J Riedel
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

6.  Fexofenadine hydrochloride in the treatment of allergic disease: a review.

Authors:  David Axelrod; Leonard Bielory
Journal:  J Asthma Allergy       Date:  2008-09-19

Review 7.  Central nervous system effects of the second-generation antihistamines marketed in Japan--review of inter-drug differences using the proportional impairment ratio (PIR)-.

Authors:  Tatsuya Isomura; Takeshi Kono; Ian Hindmarch; Norimasa Kikuchi; Aya Murakami; Kyoko Inuzuka; Seiji Kawana
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.